Synapse - Works

Results (116513)

An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck

Meeting Abstract

Foote, M.; Smithers, M.; Hong, A.; Fogarty, G.; Scolyer, R.; Paton, E.; Barker, C.; Chua, M.; Shannon, K.; Burmeister, B.; more...
Asia-Pacific Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Outcomes based on plasma biomarkers for the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)

Meeting Abstract

Parnis, F.; Rimassa, L.; Kelley, R. K.; Meyer, T.; Ryoo, B. Y.; Merle, P.; Park, J. W.; Blanc, J. F.; Lim, H. Y.; Tran, A.; more...
Asia-Pacific Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Timing the initiation of multiple myeloma

Meeting Abstract

Maura, F.; Rustad, E.; Yellapantula, V.; Bolli, N.; Leongamornlert, D.; Nadeu, F.; Angelopoulos, N.; Dawson, K.; Mitchell, T.; Osborne, R.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

INVICTUS: A phase III, interventional, double-blind, placebo-controlled study to assess the safety and efficacy of ripretinib as ≥ 4th-line therapy in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior anticancer therapies (NCT03353753)

Meeting Abstract

von Mehren, M.; Serrano, C.; Bauer, S.; Gelderblom, H.; George, S.; Heinrich, M.; Schöffski, P.; Zalcberg, J.; Chi, P.; Jones, R. L.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Registrational results of LOXO-292 in patients with RET-altered thyroid cancers

Meeting Abstract

Wirth, L.; Sherman, E.; Drilon, A.; Solomon, B.; Robinson, B.; Lorch, J.; McCoach, C.; Patel, J.; Leboulleux, S.; Worden, F.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

BEACON CRC: A randomized, 3-Arm, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BINI) versus choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer

Meeting Abstract

Desai, J.; Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Ciardello, F.; Gollerkeri, A.; Maharry, K.; more...
Asia-Pacific Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)

Meeting Abstract

González Martín, A.; Pothuri, B.; Vergote, I. B.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)

Meeting Abstract

Coleman, R. L.; Fleming, G. F.; Brady, M. F.; Swisher, E.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K.; Ben-Baruch, N.; Werner, T. L.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

5-year survival outcomes of the CheckMate 067 phase III trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma

Meeting Abstract

Larkin, J. M. G.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis

Meeting Abstract

Peters, S.; Ramalingam, S. S.; Paz-Ares, L.; Bernabe Caro, R.; Zurawski, B.; Kim, S. W.; Alexandru, A.; Lupinacci, L.; de la Mora Jimenez, E.; Sakai, H.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save